All Articles

When the origin of a cancer is unknown, it is up to pathologists to connect the dots. Here’s what Navigators need to know.

Medical insurance, employment rights, and financial toxicity! Oh my! Where can patients turn when faced with a legal issue related to their diagnosis?

Welcome to Perry County, Alabama, where Frances Ford, RN has been making a difference for 20 years.

Engagement with a multidisciplinary team and effective use of technology contributed to the improvement of oral cancer drug delivery – here’s how.

Emerging evidence suggests PARP inhibitors have the potential to revolutionize the treatment of ovarian cancer.

Patients with advanced ovarian cancer may be eligible to receive frontline maintenance treatment with olaparib plus bevacizumab.

Ovarian cancer survivors frequently use adaptive and problem-focused coping strategies. During the COVID-19 pandemic, virtual technology has played a key role in shaping and determining these strategies.

Oral treatments for ovarian cancer can be taken at home, in a sequestered environment that may minimize undue risks for patients. Results from a randomized phase 3 study suggest oral PARP inhibitor therapy has improved efficacy when compared with intravenous chemotherapy.

Telemedicine may play a critical role by creating pathways for overcoming obstacles to healthcare access, particularly for breast cancer reconstruction.